Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences. - Wikidata - wikimedia - TriplyDB

Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

http://www.wikidata.org/entity/Q37290665

about

Treatment of juvenile idiopathic arthritis: a revolution in care A successful treatment of juvenile idiopathic arthritis with rituximab: A report of two cases.

P2860

Q26849497-A8A174B4-8676-4620-A6AB-AF6CEB9913C7 Q37296422-13D17B8D-F1AF-4F98-82A8-AB11F633E940

P2860

Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

http://www.wikidata.org/entity/Q37290665

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biological therapies for the t ...... ult and pediatric experiences.

@en

Biological therapies for the t ...... ult and pediatric experiences.

@nl

type

label

Biological therapies for the t ...... ult and pediatric experiences.

@en

Biological therapies for the t ...... ult and pediatric experiences.

@nl

prefLabel

Biological therapies for the t ...... ult and pediatric experiences.

@en

Biological therapies for the t ...... ult and pediatric experiences.

@nl

P1433

Q37290665-17241F18-DDF9-43F6-B4CA-7199F5AB6FDD

P1476

Q37290665-C706842F-0C4A-4C9B-A49A-7888AD2376AC

P2093

Q37290665-8462AA96-BE9A-44D1-A1D7-603654F716E5

Q37290665-A2BE83D7-1600-4473-8723-4CE9D51963BC

P2860

Q37290665-011833B3-7DBD-422A-A28F-C1EBF0F535FC

Q37290665-01409EAE-BFE8-451D-99C3-DDE916668B4C

Q37290665-01BA076D-F36E-4C99-96BC-FB51ED43A50F

Q37290665-026E1AC1-E51F-49A0-95F5-05235A1DACB2

Q37290665-0313F020-E959-47D5-A481-21E005B00C5E

Q37290665-04422052-4E2B-4841-839C-6B6953FD1BCF

Q37290665-04F3054F-6CB0-4B13-8378-42C3143B2F12

Q37290665-05279F8D-AAA4-4829-833B-19AF577CB664

Q37290665-06688115-53F1-40A5-92CC-1CD9F50FD548

Q37290665-073A9880-62FC-4B23-8FA5-D8706BE4F74F

P304

Q37290665-6B373C15-723F-47EC-BC75-FEA60D837F8C

P31

Q37290665-6C7A75B0-ED9E-4B2A-8647-E6A1C548C6F4

P356

Q37290665-56A77BCE-04B9-4704-AEB7-8151E018D6FF

P433

Q37290665-454645F6-1A68-4DB5-89F5-7684FE2A64CE

P478

Q37290665-6D5EFE66-9C04-444A-B51F-E626D3C732A4

P577

Q37290665-269C1019-9267-4F31-8537-731B3DD919CD

P5875

Q37290665-FF40408C-10C1-4AC9-8CA3-8884AE076BBF

P698

Q37290665-796B984D-2B41-48C5-AB74-7E90E7D953B7

P921

Q37290665-E560ABCF-E1F5-433E-A6AC-203794655C03

P932

Q37290665-E2DED805-3E93-4569-BF4D-02982668187F

P356

P1433

Biologics: Targets and Therapy

P1476

Biological therapies for the t ...... ult and pediatric experiences.

@en

P2093

Alisa C Gotte

http://www.w3.org/2001/XMLSchema#string

Matthew L Stoll

http://www.w3.org/2001/XMLSchema#string

P2860

An endotoxin-induced serum factor that causes necrosis of tumors

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis

Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolong

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

P304

229-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/BTT.S2210

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26767408

http://www.w3.org/2001/XMLSchema#string

P698

19707357

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis

P932

2721362

http://www.w3.org/2001/XMLSchema#string